These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Nearly circumferential delayed contrast enhancement in severe ischemic cardiomyopathy. Leurent G; Donal E; Langella B Arch Cardiovasc Dis; 2008 Jan; 101(1):70-1. PubMed ID: 18391877 [No Abstract] [Full Text] [Related]
9. eComment: Insights in the reshaping of the ischemic ventricle. Lentini S; Murè P; Tancredi F; Gaeta R Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):707-8. PubMed ID: 18664675 [No Abstract] [Full Text] [Related]
10. Causes of repeated remodeling of left ventricle after Dor procedure. Shipulin VM; Kazakov VA; Suhodolo IV; Krivoshekov EV; Lezhnev AA; Kozlov BN; Vaizov VCh; Miller AA Interact Cardiovasc Thorac Surg; 2007 Dec; 6(6):772-7. PubMed ID: 17884848 [TBL] [Abstract][Full Text] [Related]
11. Potential Strategies for Clinical Translation of Repeated Cell Therapy. Vrtovec B; Bolli R Circ Res; 2019 Mar; 124(5):690-692. PubMed ID: 30817255 [TBL] [Abstract][Full Text] [Related]
12. Reverse-remodeling after coronary artery bypass grafting in ischemic cardiomyopathy: assessment of myocardial viability by delayed-enhanced magnetic resonance imaging can help cardiac surgeons. Ogawa M; Doi K; Fukumoto A; Yaku H Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):673-5. PubMed ID: 17670732 [TBL] [Abstract][Full Text] [Related]
13. Impact of surgical ventricular restoration on stroke volume: surgical fine-tuning of the relationship between end-diastolic volume and stroke volume. Adhyapak SM; Parachuri VR J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1552-3; author reply 1553-4. PubMed ID: 21596175 [No Abstract] [Full Text] [Related]
14. CD34+ autologous human stem cells in treating refractory angina. Perin EC; Willerson JT Circ Res; 2011 Aug; 109(4):351-2. PubMed ID: 21817161 [No Abstract] [Full Text] [Related]
17. Successful recovery using surgical intervention to treat ischemic cardiomyopathy and cardiogenic shock. Unosawa S; Hata M; Sezai A; Niino T; Yoshitake I; Shimura K; Nagao K; Minami K Ann Thorac Cardiovasc Surg; 2010 Aug; 16(1):52-4. PubMed ID: 20190712 [TBL] [Abstract][Full Text] [Related]
18. Establishing new porcine ischemic cardiomyopathy model by transcatheter ischemia-reperfusion of the entire left coronary artery system for preclinical experimental studies. Shudo Y; Miyagawa S; Fukushima S; Saito A; Kawaguchi N; Matsuura N; Sawa Y Transplantation; 2011 Oct; 92(7):e34-5. PubMed ID: 21952307 [No Abstract] [Full Text] [Related]
19. Biodegradable vs Nonbiodegradable Cardiac Support Device for Treating Ischemic Cardiomyopathy in a Canine Heart. Kitahara M; Miyagawa S; Fukushima S; Saito A; Shintani A; Akita T; Sawa Y Semin Thorac Cardiovasc Surg; 2017 Spring; 29(1):51-61. PubMed ID: 28683998 [TBL] [Abstract][Full Text] [Related]
20. Use of quantitative analysis of remote myocardial fibrosis with delayed-enhancement magnetic resonance imaging to predict outcomes after surgical ventricular restoration for ischemic cardiomyopathy. Takeda K; Matsumiya G; Matsue H; Hamada S; Sakaki M; Sakaguchi T; Fujita T; Sawa Y J Thorac Cardiovasc Surg; 2008 Dec; 136(6):1514-21. PubMed ID: 19114200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]